Treatment of Primary Insomnia

References

1. ↵
   The Gallup Organization. Sleep in America: a national survey of US adults. Washington DC: National Sleep Foundation; 1995.
2. ↵
   Kiley J. Insomnia research and future opportunities. Sleep 1999; 22 Suppl 1: S344–5.

   OpenUrl
3. ↵
   Meyer TJ. Evaluation and management of insomnia. Hosp Pract (Off Ed) 1998; 33: 75–8, 83–6.

   OpenUrlCrossRefPubMed
4. ↵
   Eddy M, Walbroehl G. Insomnia. Am Fam Physician 1999; 59: 1911–6.

   OpenUrlPubMed
5. ↵
   American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psychiatric Association; 1994.
6. ↵
   Wagner J, Wagner M, Hening W. Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia. Ann Pharmacother 1998; 32: 680–91.

   OpenUrlAbstract/FREE Full Text
7. ↵
   Lacks P, Morin C. Recent advances in the assessment and treatment of insomnia. J Consult Clin Psychol 1992; 60: 586–94.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   Diagnostic Classification Steering Committee of the America Sleep Disorders Association. International classification of sleep disorders—diagnostic and coding manual. Rochester (MN): American Sleep Disorders Association; 1990.
9. ↵
   Jones C, Czajkowski L. Evaluation and management of insomnia in menopause. Clin Obstet Gynecol 2000; 43: 184–97.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    Attarian H. Helping patients who say they cannot sleep. Postgrad Med 2000; 7: 127–42.
11. ↵
    Ancolu-Isreal S. Insomnia in the elderly: a review for the primary care practitioner. Sleep 2000; 23 Suppl 1: S23–38.

    OpenUrlPubMed
12. ↵
    Morin C, Mimeault V, Gagne A. Nonpharmacological treatment of late-life insomnia. 1999 J Psychosom Res 1999; 46: 103–16.
13. ↵
    Simon G, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997; 154: 1167–23.

    OpenUrl
14. ↵
    Rakecki S, Brunton A. Management of insomnia in office-based practice. Arch Fam Med 1993; 2: 1129–34.

    OpenUrlCrossRefPubMed
15. ↵
    Buysee D, Reynolds C, Kupfer D, et al. Clinical diagnosis in 216 insomnia patients using the International Classification of Sleep Disorders (ICSD), DSM-IV, and ICD-10 categories: a report from the APA/NIMH DSM-IV field trial. Sleep 1994; 17: 630–7.

    OpenUrlPubMedWeb of Science
16. ↵
    Bastien C, Morin C. Familial incidence of insomnia. J Sleep Res 2000; 9: 45–54.

    OpenUrl
17. ↵
    American Sleep Disorders Association. Practice parameters for the use of portable recording in the assessment of obstructive sleep apnea. Standards of Practice Committee of the American Sleep Disorders Association. Sleep 1994; 17: 372–7.

    OpenUrlPubMedWeb of Science
18. ↵
    Smith M, Perlis M, Park A, et al. Comparative Meta-analysis of pharmacotherapy and behavior therapy for persistent insomia. Am J Psychiatry 2002; 159: 5–11.

    OpenUrlCrossRefPubMedWeb of Science
19. ↵
    Edinger J, Wohlgemuth W, Radtke R, Marsh G, Quillian R. Cognitive behavioral therapy for treatment of chronic primary insomnia. JAMA 2001; 285: 1856–64.

    OpenUrlCrossRefPubMedWeb of Science
20. ↵
    Morin C, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia. JAMA 1999; 284: 991–9.

    OpenUrl
21. ↵
    Holbook A, Crowther R, Lotter A, Cheng C, King D. The diagnosis and management of insomnia in clinical practice: a practice evidence-based approach. Can Med Assoc J 2000; 162: 210–6.

    OpenUrlFREE Full Text
22. ↵
    King A, Oman R, Brassington G, Bliswise D, Haskell W. Moderate intensity exercise and self-rated quality of sleep in older adults: a randomized controlled trial. JAMA 1997; 277: 32–7.

    OpenUrlCrossRefPubMedWeb of Science
23. ↵
    Morin C, Culbert J, Schwartz S. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 1994; 151: 1172–80.

    OpenUrlPubMedWeb of Science
24. ↵
    Hendrix S. Nonestrogen management of menopausal symptoms. Endocrinol Metab Clin North Am 1997; 26: 379–90.

    OpenUrlPubMed
25. ↵
    Roehrs T, Papineau K, Rosenthal L, Roth T. Ethanol as a hypnotic in insomniacs: self administration and effects on sleep and mood. Neuropsychopharmacology 1999; 20: 279–86.

    OpenUrlCrossRefPubMedWeb of Science
26. ↵
    Avery D, Lenz M, Landis C. Guidelines for prescribing melatonin. Ann Med 1998; 30: 122–30.

    OpenUrlPubMedWeb of Science
27. ↵
    Shochat T, Haimov I, Lavie P. Melatonin—the key to the gate of sleep. Ann Med 1998; 30: 81–7.

    OpenUrlPubMed
28. ↵
    Arendt J, Deacon S. Treatment of circadian rhythm disorders—melatonin. Chronobiol Int 1997; 14: 185–204.

    OpenUrlPubMedWeb of Science
29. ↵
    Zhdanova IV, Wurtman RJ, Regan MM, Taylor JA, Shi JP, LeClair OU. Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab 2001; 86: 4727–30.

    OpenUrl
30. ↵
    Snitker JA, Bell WL, Schweain SL, Short RM, Burnham TH. Valerian. The review of natural products. St. Louis: Facts and Comparisons; 1999. p. 1–2.
31. ↵
    Consumer advisory: Kava-containing dietary supplements may be associated with severe liver injury. Rockville (MD): Center for Food Safety and Applied Nutrition, US Food and Drug Administration; 2002 [cited 2003 Oct 28]. Available from http://www.cfsan.fda.gov/%7Edms/addskava.html.
32. ↵
    Mitler MM. Nonselective and selective benzodiazepine receptor agonists—where are we today? Sleep 2000; 23 Suppl 1: S39–47.

    OpenUrlPubMed
33. ↵
    Wysowski D, Barash D. Adverse behavioral reactions attributed to triazolam in the Food and Drug Administration’s Spontaneous Reporting System. Arch Intern Med 1991; 151: 3003–8.

    OpenUrl
34. ↵
    Kallepalli B, Bhatara V, Fogas B, Tervo R, Misra L. Trazodone is only slightly faster than fluoxetine in relieving insomnia in adolescents with depressive disorders. J Child Adolesc Psychopharmacol 1997; 7: 97–107.

    OpenUrlPubMed
35. ↵
    MICROMEDEX Healthcare Series Integrated Index–Drugdex drug evaluations: FDA labeled use–insomnia. Greenwood Village (CO): Thomson MICROMEDEX; 2003.